Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Biotricity, Inc. BTCY
$0.61
-$0 (-0.53%)
На 18:03, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
31241315.00000000
-
week52high
1.92
-
week52low
0.40
-
Revenue
7650269
-
P/E TTM
-2
-
Beta
2.37854600
-
EPS
-0.47000000
-
Last Dividend
0.00000000
-
Next Earnings Date
12 июл 2023 г. в 12:00
Описание компании
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Maxim Group | Hold | Buy | 15 июл 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 15 июл 2022 г. |
| Lake Street | Buy | 07 мар 2022 г. | |
| HC Wainwright & Co. | Buy | 23 ноя 2021 г. | |
| Northland Capital Markets | Outperform | 01 июл 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Betts Norman M. | A | 375598 | 54348 | 29 ноя 2021 г. |
| Rosa David A | A | 152174 | 27174 | 29 ноя 2021 г. |
| Rosa David A | D | 125000 | 3318 | 11 окт 2021 г. |
| Rosa David A | D | 128318 | 9481 | 08 окт 2021 г. |
| Rosa David A | D | 137799 | 17228 | 07 окт 2021 г. |
| Rosa David A | D | 155027 | 34977 | 16 сент 2021 г. |
| Rosa David A | D | 190004 | 6246 | 15 сент 2021 г. |
| Rosa David A | A | 398753 | 31106 | 21 мар 2021 г. |
| Al-Siddiq Waqaas | A | 1400000 | 1400000 | 07 апр 2020 г. |
| Betts Norman M. | A | 321250 | 125000 | 07 апр 2020 г. |
Новостная лента
Biotricity Selected to Present its Work on AI Enabled Stroke Prediction in CKD Patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference
Accesswire
03 февр 2023 г. в 09:00
REDWOOD CITY, CA / ACCESSWIRE / February 3, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is excited to announce that it is one of only eight companies selected to present at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference (ISC), being held in Dallas, TX. The showcase is being co-hosted by ISC in collaboration with both the National Heart, Lung, and Blood Institute and the National Institute for Neurological Disorders and Stroke (NINDS).
Biotricity to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET
Accesswire
23 янв 2023 г. в 08:30
REDWOOD CITY, CA / ACCESSWIRE / January 23, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced today that Company CEO Waqaas Alsiddiq has been invited to present at the Healthcare IT Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Wednesday, January 25th, 2023 at 8:15 a.m. ET. Please join us for the upcoming conference on Healthcare IT.
Biotricity, Inc. (BTCY) Q2 2023 Earnings Call Transcript
Seeking Alpha
14 ноя 2022 г. в 21:54
Biotricity, Inc. (NASDAQ:BTCY ) Q2 2023 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Valter Pinto - Managing Director, KCSA Strategic Communications Waqaas Al-Siddiq - Chairman, Chief Executive Officer & Founder John Ayanoglou - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Michael Donovan - H.C. Wainwright Operator Good day, and welcome to the Biotricity's Fiscal Second Quarter 2023 Financial Results Conference Call.
Biotricity to Host Fiscal 2023 Second Quarter Financial Results on November 14th at 4:30 PM ET
Accesswire
01 ноя 2022 г. в 08:30
REDWOOD CITY, CA / ACCESSWIRE / November 1, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it will host a conference call on Monday, November 14, 2022 at 4:30 p.m. ET to discuss its financial results for the fiscal 2023 second quarter and provide a business update.
Biotricity, Inc. (BTCY) CEO Waqaas Siddiq on Q1 2023 Results - Earnings Call Transcript
Seeking Alpha
15 авг 2022 г. в 21:24
Biotricity, Inc. (NASDAQ:BTCY ) Q1 2023 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Valter Pinto - Managing Director, KCSA Strategic Communications Waqaas Siddiq - Chairman, Chief Executive Officer and Founder John Ayanoglou - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital markets Kevin Dede - HC Wainwright Operator Good day and welcome to the Biotricity's Fiscal First Quarter 2023 Financial Results Conference Call. Today's conference is being recorded.